Spencer Knight is a Research Director at General Atlantic and focuses on investments in the firm’s Life Sciences Sector. Before joining General Atlantic in 2023, Spencer was a Senior Director and Head of Computational Biology at Kriya Therapeutics. Prior to that, he was a Senior Genomic Data Scientist at Ancestry and a Co-founder at Algen Biotechnologies. Spencer began his career as a Data Scientist at Foresite Capital.